Last reviewed · How we verify
Other Antipsychotics - New Starts — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Other Antipsychotics - New Starts (Other Antipsychotics - New Starts) — Janssen Scientific Affairs, LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Other Antipsychotics - New Starts TARGET | Other Antipsychotics - New Starts | Janssen Scientific Affairs, LLC | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Other Antipsychotics - New Starts CI watch — RSS
- Other Antipsychotics - New Starts CI watch — Atom
- Other Antipsychotics - New Starts CI watch — JSON
- Other Antipsychotics - New Starts alone — RSS
Cite this brief
Drug Landscape (2026). Other Antipsychotics - New Starts — Competitive Intelligence Brief. https://druglandscape.com/ci/other-antipsychotics-new-starts. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab